Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fibrosis pathway is a complex network of cellular and molecular processes that lead to the excessive deposition of extracellular matrix (ECM) components, resulting in tissue scarring and hardening. This process is primarily driven by myofibroblasts, which are activated in response to chronic injury or inflammation. Key mediators include TGF-β, Wnt/β-catenin, and CTGF. Dysregulation of this pathway can cause progressive organ dysfunction and failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrosis Pathway.